Search results
Tony Kouzarides is a Professor of Cancer Biology at the University of Cambridge and a co-founder of the Milner Therapeutics Institute. His lab studies epigenetic modifications and their role in cancer, especially RNA modifications and METTL3 inhibition.
May 11, 2021 · Tony Kouzarides is a professor of cancer biology and a director of the Milner Therapeutics Institute. He studies epigenetic modifications and their roles in cancer, and co-founded several biotech companies.
kouzarides_tony_885_x_432.png Professor of Cancer Biology and Director and Co-Founder, Milner Institute Tony Kouzarides works on the characterization of the pathways leading to epigenetic modifications of Histones and their involvement in cancer.
Tony Kouzarides is Professor of Cancer Biology at the University of Cambridge and a group leader at the Gurdon Institute. He currently holds the following directorships: Director and Co-founder of the Milner Therapeutics Institute, director of Cambridge Gravity and director of STORM Therapeutics . Tony is founder/director of Cambridge Gravity ...
Tony Kouzarides is a leading researcher in chromatin and RNA modifications and their roles in cancer. He is the director of the Milner Therapeutics Institute and co-founder of several biotech companies.
Peter Tessarz, Helena Santos-Rosa, Sam C. Robson, Kathrine B. Sylvestersen,Christopher J Nelson, Michael L. Nielsen & Tony Kouzarides. (2014) Glutamine methylation in Histone H2A is an RNA Polymerase I dedicated modification. Nature. 505(7484), 564-568. Blerta Xhemalce, Sam Robson & Tony Kouzarides.
People also ask
Who is Tony Kouzarides?
Who is Tony Gurdon?
What does Kouzarides do?
Where did Kouzarides go to study epigenetic modification?
Tony Kouzarides is a leading researcher on epigenetic modifications and cancer. He is the Deputy Director of the Gurdon Institute, the Director of the Milner Therapeutics Institute and the founder of several biotech companies.
